Consolidative Stem Cell Transplant May Improve Outcomes in PTCL
Researchers sought to determine whether patients with PTCL who have a complete response after A+CHP would benefit from SCT.
All articles by John Eckman
Bendamustine-Rituximab Induction Appears Effective in Mantle Cell Lymphoma
First-line bendamustine plus rituximab followed by ASCT and rituximab maintenance appears effective in mantle cell lymphoma.
Zanubrutinib Appears Superior to Ibrutinib in Patients With Relapsed/Refractory CLL/SLL
Researchers sought to compare zanubrutinib with ibrutinib in patients with CLL/SLL.
Venetoclax Plus Azacitidine Appears Promising in High-Risk MDS, CMML
Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.
Immunotherapy and Targeted Therapies in NSCLC: Phase 3 Data From ESMO 2022
Results from the CodeBreak 200, EMPOWER-Lung 1, IPSOS, and ADAURA trials highlight the efficacy of immunotherapy and targeted therapies in non-small cell lung cancer.
Real-World Analysis Reveals Treatment, Survival Trends in Mantle Cell Lymphoma
Researchers sought to determine the treatment and survival trends for patients with mantle cell lymphoma.
Integrating KMT2A-PTD into DNA NGS to Predict Outcomes in AML, MDS
Integrating the assessment of KMT2A-PTD into standard DNA sequencing may be prognostically valuable for patients with MDS or AML.
Several Factors May Predict Risk of ILD/Pneumonitis After Trastuzumab Deruxtecan
The risk of ILD/pneumonitis was associated with patient age, time since cancer diagnosis, dose of trastuzumab deruxtecan, and other factors.
Incidence of Distant-Stage Cervical Cancer Increasing in the US
The incidence of distant-stage cervical cancer in the United States increased by 1.3% per year from 2001 to 2018.
Gefitinib Plus Chemo Improves PFS2 Over Gefitinib Alone in EGFR-Mutant NSCLC
Patients who received gefitinib plus platinum chemotherapy had significantly longer PFS2 than patients who received gefitinib alone.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...